Experts stress on collaboration, between industry, research centres and academic institutions.
A one-day symposium, ‘Stem Cells and Cancer-India 2018’, recently brought together renowned personalities in the field of cancer research at Mumbai “to highlight the most updated research and information available in the area of cancer stem cell therapy”.
Organised jointly by Sathgen Biotech, National Centre for Cell Sciences and Somaiya Vidyavihar, the symposium saw the likes of Dr Michael Clarke, a pioneer in stem cell therapy of cancer, academicians, research students and industry delegates.
Samir Somaiya, Chairman and Managing Director, Godavari Biorefineries, of which Sathgen Biotech is a division, said, “Since its inception in 2007 Sathgen Biotech has been working on developing drugs, which could work to eliminate cancer stem cell population, drugs which will also work in combination with existing chemotherapies to eliminate cancer-related mortality. Stem cell therapy is a new targeted method being evaluated by various academic and research groups across the globe.”
“This symposium is being organised to address the most updated research and information available in the area of cancer stem cell therapy. We believe that collaboration between Industry, Research Centres and Academic Institutions can work towards finding new and innovative methods to understand cancer & eventually circumvent it,” Somaiya added.
Dr Michael Clarke, Associate Director of Stanford Institute for Stem Cell and Regenerative Medicine, explained the role of stem cells in the treatment of degenerative diseases.
“There is a need for advancing research in the area of Cancer. Collaborations and discussions like these will bring in fresh new thinking and innovation. New paradigms from analytical tools to a deeper understanding of risk factors; from biomarkers to drug resistance and tumour recurrence are some of the many perspectives that have to be studied. The increase in cancer worldwide and the younger age at which it is occurring needs a clarion call for to come together and find solutions,” Dr Clarke said.
Dr Vijay Joshi, Principal KJ Somaiya College of Science and Commerce, said, “The stem cells are mother cells of all cell type and are being used in various diseases to cure the anomaly. In a cancer tumour even after radiation and chemotherapy, a very small fraction of the cell remains alive and cause recurrence of cancer.We need to understand this complexity to have better therapeutic options in future. To explore this new avenue of science individual scientist from fundamental research arena need to come together with industry and academics”.
The conference was organised at Somaiya Vidyavihar to enlighten students of Medical & Science College and other colleges about stem cells and cancer, pooling together the recent advances from the scientists and industry
“Attending the symposium on stem cells and cancer was an extraordinary experience. There was a lot to learn from the lectures about recent advancements in cancer and stem cell technology. I got to learn a lot from the esteemed dignitariesspeaking atthe conference. I am inspired to work in this important area,” said Kunal D. Palan, a post-graduate student of Biochemistry at KJ Somaiya College of Science and Commerce.
Komal Padhariya, PhD Scholar, from NMIMS Mumbai, who attended the symposium, said, “I am delighted to be present at the symposium on stem cells and cancer. The conference enlightened many interesting topics in the field of stem cells and cancer for students to work in the future. I’m glad that I was a part of the conference and got to learn so much”.
Sathgen Biotech is a division of Godavari Biorefineries Ltd and is actively involved in anti-cancer drug screening using novel methods. The laboratory has achieved some major breakthroughs in developing few anti-cancer stem cell molecules, which are showing better performance than the standard chemotherapeutic drugs. Shortly, these molecules would be taken ahead for IND filings and further preclinical trials. One of these molecules has received Government of India (BIRAC) grant.
Speakers at the conference included renowned personalities in the field of cancer research.
